Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges | Current Treatment Options in Oncology
Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors | Oncogene
Diagnostics | Free Full-Text | Update on Molecular Genetics of Gastrointestinal Stromal Tumors
KIT exon 11 and PDGFRA exon 18 gene mutations in gastric GIST: proposal of a short panel for predicting therapeutic response | Surgical and Experimental Pathology | Full Text
GIST with PDGFR Alpha Mutations | GIST Support International
Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis | Scientific Reports
Cancers | Free Full-Text | The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)
IJMS | Free Full-Text | Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors
Sensitivity profile of ripretinib in KIT-mutant GIST across known... | Download Scientific Diagram
Mechanism of action of imatinib. A) Under physiological conditions, ATP... | Download Scientific Diagram
FGF/FGFR Pathway in GIST | Encyclopedia MDPI
Diagnosing GIST | GIST Support International
Distribution of KIT and PDGFRA mutations in GIST. Frequency of... | Download Scientific Diagram